Lantern Pharma Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Lantern Pharma Inc. (LTRN) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $4.62 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2022-11-07
- 2022-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $4.62M.
- 2022-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $18.79M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months |
|---|---|
| 2022-09-30 | $4.62M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $18.79M 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |